An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment
- Status
- UNKNOWN
- Phase
- N/A
Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure
- Status
- TERMINATED
- Phase
- PHASE2
Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative Colitis
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy
- Status
- COMPLETED
- Phase
- PHASE3
COMRADE: Collaborative Care Management for Distress and Depression in Rural Diabetes
- Status
- COMPLETED
- Phase
- NA
A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL)
- Status
- COMPLETED
- Phase
- PHASE2
Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices
- Status
- COMPLETED
- Phase
- N/A
Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab
- Status
- COMPLETED
- Phase
- N/A
Early Patient Access Treatment Use Protocol CA204-220
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Yervoy Pregnancy Surveillance Study
- Status
- WITHDRAWN
- Phase
- N/A
Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice
- Status
- COMPLETED
- Phase
- N/A
Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE1
Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Treatment Patterns, Outcomes and Resource Use Study for Advanced Stage Non-Small Cell Lung Cancer (Squamous and Non-squamous) in the Kingdom of Saudi Arabia and United Arab Emirates
- Status
- COMPLETED
- Phase
- N/A
Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
Elotuzumab, Lenalidomide and Dexamethasone in Treatment of Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Sub-Clinical Atrial Fibrillation Biomarker Study
- Status
- COMPLETED
- Phase
- N/A
Long-term Epidemiological Follow-up of Non-small Cell Lung Cancer in Scandinavia
- Status
- COMPLETED
- Phase
- N/A